A Phase 1 Study Evaluating the Safety,Pharmacokinetics, and Anti-Tumor Activity ofABBV-321 in Subjects with Advanced Solid TumorsAssociated with Overexpression of the EpidermalGrowth Factor Receptor (EGFR)

Project: Research project

Project Details

Description

A Phase 1 Study Evaluating the Safety, Pharmacokinetics, and Anti-Tumor Activity of ABBV-321 in Subjects with Advanced Solid Tumors Associated with Overexpression of the Epidermal Growth Factor Receptor (EGFR)
StatusActive
Effective start/end date5/26/206/1/26

Funding

  • ABBVIE INC.

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.